Daiwa Securities Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12K | Hold |
215
| – | – | ﹤0.01% | 1114 |
|
|
2025
Q1 | $10K | Hold |
215
| – | – | ﹤0.01% | 1098 |
|
|
2024
Q4 | $8K | Hold |
215
| – | – | ﹤0.01% | 1135 |
|
|
2024
Q3 | $10K | Hold |
215
| – | – | ﹤0.01% | 1132 |
|
|
2024
Q2 | $7K | Hold |
215
| – | – | ﹤0.01% | 1172 |
|
|
2024
Q1 | $6K | Buy |
215
+52
| +32% | +$1.45K | ﹤0.01% | 1189 |
|
|
2023
Q4 | $4K | Hold |
163
| – | – | ﹤0.01% | 1222 |
|
|
2023
Q3 | $3K | Hold |
163
| – | – | ﹤0.01% | 1196 |
|
|
2023
Q2 | $5K | Hold |
163
| – | – | ﹤0.01% | 1175 |
|
|
2023
Q1 | $4K | Hold |
163
| – | – | ﹤0.01% | 1157 |
|
|
2022
Q4 | $2K | Hold |
163
| – | – | ﹤0.01% | 1226 |
|
|
2022
Q3 | $1K | Hold |
163
| – | – | ﹤0.01% | 1300 |
|
|
2022
Q2 | $1K | Hold |
163
| – | – | ﹤0.01% | 1303 |
|
|
2022
Q1 | $4K | Hold |
163
| – | – | ﹤0.01% | 1193 |
|
|
2021
Q4 | $6K | Hold |
163
| – | – | ﹤0.01% | 1176 |
|
|
2021
Q3 | $3K | Buy |
163
+82
| +101% | +$1.51K | ﹤0.01% | 1219 |
|
|
2021
Q2 | $4K | Hold |
81
| – | – | ﹤0.01% | 1089 |
|
|
2021
Q1 | $2K | Hold |
81
| – | – | ﹤0.01% | 1155 |
|
|
2020
Q4 | $2K | Sell |
81
-115
| -59% | -$2.84K | ﹤0.01% | 1130 |
|
|
2020
Q3 | $4K | Buy |
196
+42
| +27% | +$857 | ﹤0.01% | 1094 |
|
|
2020
Q2 | $1K | Hold |
154
| – | – | ﹤0.01% | 1175 |
|
|
2020
Q1 | $1K | Hold |
154
| – | – | ﹤0.01% | 1184 |
|
|
2019
Q4 | $1K | Buy |
+154
| New | +$1K | ﹤0.01% | 1174 |
|